Quarterly report [Sections 13 or 15(d)]

Summary of Significant Accounting Policies (Tables)

v3.25.3
Summary of Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2025
Accounting Policies [Abstract]  
Schedule of Anti-dilutive Securities

The following common stock equivalents were excluded in the computation of the net loss per share because their effect is anti-dilutive:

 

   

September 30, 2025

(Unaudited)

   

September 30, 2024

(Unaudited)

 
Series L convertible preferred stock 1     7,649,792        
Options to purchase common stock     597,550       101,264  
Warrants to purchase common stock     49,459,390       1,133,762  
Total anti-dilutive securities     57,706,732       1,235,026  

 

1 Converted into common stock using a conversion price of $0.6421 per share, as of September 30, 2025